<style face="normal" font="default" size="100%">Pharmacokinetic/pharmacodynamic adequacy of polymyxin B against extensively drug-resistant Gram-negative bacteria in critically ill, general ward and cystic fibrosis patient populations</style>

Drupal-Bibcite